CClinicalTrials.gg
CompletedNCT03733847Updated Oct 28, 2019

Rehabilitation Trajectories

An observational study in Musculoskeletal Disease, sponsored by National Resource Center for Rehabilitation in Rheumatology. Completed. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2019-10-28.

Sponsored by National Resource Center for Rehabilitation in Rheumatology · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
524
Ages
18 Years to 100 Years
Sex
All
01

Study summary

The main aim of this multicentre cohort study is to provide evidence that can be used to improve continuity and quality in rehabilitation practice and rehabilitation processes across health care levels for patients with rheumatic and musculoskeletal diseases (RMDs).

Read the detailed description

There is an urgent need to develop rehabilitation trajectories that ensure coordination and communication between health care levels, support of self-management and self-monitoring, and follow-up tailored to patients' needs. Such trajectories should be based on evidence from current practice. The "Rehabilitation trajectories" project will systematically explore and describe current practice of planned and implemented follow-up and self-management strategies in primary health care during the first year after rehabilitation for patients with musculoskeletal diseases. Further, a newly developed core set of PROMs designed for evaluation of rehabilitation in RMDs and a self-monitoring web-based system will be tested for feasibility. Knowledge of patients' experiences and use of this self-monitoring system as a self-management and communication tool is needed in order to improve and integrate such e-technology in future care.

The Rehabilitation Trajectory study is a multi-centre study, led by the National Unit on Rehabilitation in Rheumatology and including participants at four rheumatology hospital departments and five specialized rehabilitation institutions. Participants will thus be included from all four health regions in Norway.

The study has five points of assessment. In an electronic portal, delivered by CheckWare, patients will log in with their Bank ID and complete the core set of PROMs at admission, discharge, and 4, 8 and 12 months following discharge.

02

Conditions studied

  • Musculoskeletal Disease
03

In context

Musculoskeletal Diseases

657 studies on the registry are indexed under Musculoskeletal Diseases; 159 are open to participants now.

This study's enrollment of 524 is above the median of 126 across 201 observational studies indexed under Musculoskeletal Diseases.

Browse Musculoskeletal Diseases studies →

Lead sponsor

National Resource Center for Rehabilitation in Rheumatology is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with rheumatic and musculoskeletal diseases from Norway admitted to rehabilitation at one of the nine participating rehabilitation centres.

Inclusion criteria

  • Admitted to rehabilitation at one of the nine participating rehabilitation centres with one of the following groups of diagnosis: Inflammatory rheumatic disease, Osteoarthritis, Low back pain, Neck/shoulder pain, Generalized pain syndromes (including fibromyalgia), Osteoporosis, Connective tissue diseases (SLE, Lupus, Myositis etc.), Fractures with need of rehabilitation, or Rehabilitation after orthopaedic surgery. Good proficiency in oral and written Norwegian language. Access to internet and BankID.

Exclusion criteria

Exclusion Criteria:

  • Cognitive impairment or severe mental illness.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
524 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Goal attainment

    Goal attainment will be measures by the Patient Specific Functional Scale. Scale from 0 to 10, were 10 is the best score. Mean score is calculated from all activites scored.

    Time frame: One year

Secondary outcomes

  1. Health-realted quality of life

    Health-realted quality of life will be measured by the EQ5D

    Time frame: One year

  2. Physical function

    Physical function will be measured by the 30 seconds sit to stand test

    Time frame: One year

Other outcomes

  1. General Pain

    Pain will be measured on a numeric rating scale (NRS). Pain is measured on a subjective scale from 0 to 10, were 0 is no pain and 10 is the worst pain.

    Time frame: One year

  2. Fatigue

    Fatigue will be measured on a numeric rating scale (NRS). Fatigue is measured on a subjective scale from 0 to 10, were 0 is no fatiuge and 10 is the worst abount of fatigue.

    Time frame: One year

  3. Motivation for goal attainment

    Motivation for goal attainment will be measured on a numeric rating scale (NRS). Motivation is measured on a subjective scale from 0 to 10, were 0 is no motviation and 10 is the best and highest motivation.

    Time frame: One year

  4. Function in daily acitvities

    Daily activities will be measured by the Hannover Functional Ability Questionnair

    Time frame: One year

  5. Coping

    Coping will be measures by the Effective Musculoskeletal Consumer Scale. The scale goes from 0 to 4, were 0 stated "never" and 4 states "always".

    Time frame: One year

  6. Mental health

    Mental health will be measured by the Hopkins Symptoms Checklist

    Time frame: One year

  7. Participation

    Participation will be measured by the participation scale in COOP/WONKA

    Time frame: One year

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 28, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03733847
Lead sponsor
National Resource Center for Rehabilitation in Rheumatology
Collaborators
Haugesund Rheumatism Hosptial AS, Betanien Hospital, Vikersund Rehabilitation Center AS, Meråker Rehabilitation Center, North Norway Rehabilitation Center, UniCare Jeløy, Sørlandet Hospital, Innlandet HF Konsvinger Hospital, Rehab Vest Rehabilitation Hospital
Responsible party
Ingvild Kjeken (Professor, National Resource Center for Rehabilitation in Rheumatology) — Principal investigator
First posted
Nov 7, 2018
Start date
Nov 1, 2015
Primary completion
Dec 31, 2017
Completion
Dec 31, 2017
Last update
Oct 28, 2019

Study contacts

Tore K Kvien, PhD
study director · Diakonhjemmet Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion